Updates from ASH in Later Line Multiple Myeloma Management

 

Insights from 2023 ASH Annual Meeting
Avatar

ASH 2023 Insights: "KarMMa-3 Trial - Ide-Cel vs. Standard Regimens in Patients With Triple-Class-Exposed R/R MM"

By Insights from 2023 ASH Annual Meeting FEATURING Krina Patel
By Insights from 2023 ASH Annual Meeting FEATURING Krina Patel
80 views
February 12, 2024
0 Comments
Login to view comments. Click here to Login
Updates from ASH in Later Line Multiple Myeloma Management
22:50
MyCancerHaven

Experts Discuss How to Choose Between CAR-Ts and Bispecifics in Myel…

Feat. R. Vij, N. Nathwani
14:34
Krina Patel

Early Line CAR-Ts in Myeloma - Updates and Future Directions

03:42
Moffitt Cancer Center

New FDA Approvals of CAR-Ts Earlier in Myeloma: What You Need to Know

Feat. D. Hansen
22:50
Indy Hematology Review

Emerging and Cellular Therapeutic Options for MM: Understanding Your…

Feat. S. Usmani
50:49
UChicago Medicine

Car T-Cells and Bispecifics in Myeloma: A Case for Moving Them Early

Feat. N. Raje
21:14
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates on the Role of Immunotherapy for MM

Feat. A. Cohen
24:29
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

How I Treat R/R MM With CAR-T and Bispecific Antibodies

Feat. C. Cerchione
25:42
5th SOHO Italy Annual Conference

SOHO Italy 2023: New Insights and Opportunities for Lenalidomide Ref…

Feat. J. San-Miguel
06:14
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Inflammatory Biomarkers and Outcomes in MM …

Feat. D. Pan
08:11
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "KarMMa-3 Trial - Ide-Cel vs. Standard Regim…

Feat. K. Patel
04:30
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "KarMMa-2 Extended Follow-Up - Ide-Cel in Pt…

Feat. M. Alsina
09:05
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "KarMMa-3 Trial - Effects of Ide-Cel vs. Sta…

Feat. M. Delforge
49:01
Scripps MD Anderson Cancer Center

Current Summary of the Multiple Myeloma Treatment Landscape

Feat. R. Lu
24:39
Icahn School of Medicine at Mount Sinai

Adverse Effects of CAR-T: Myeloma Edition

Feat. S. Rajeeve